_version_ 1784855893079228416
author Ponzo, Matteo
Debesset, Anais
Cossutta, Mélissande
Chalabi-Dchar, Mounira
Houppe, Claire
Pilon, Caroline
Nicolas-Boluda, Alba
Meunier, Sylvain
Raineri, Fabio
Thiolat, Allan
Nicolle, Rémy
Maione, Federica
Brundu, Serena
Cojocaru, Carina Florina
Bouvet, Philippe
Bousquet, Corinne
Gazeau, Florence
Tournigand, Christophe
Courty, José
Giraudo, Enrico
Cohen, José L.
Cascone, Ilaria
author_facet Ponzo, Matteo
Debesset, Anais
Cossutta, Mélissande
Chalabi-Dchar, Mounira
Houppe, Claire
Pilon, Caroline
Nicolas-Boluda, Alba
Meunier, Sylvain
Raineri, Fabio
Thiolat, Allan
Nicolle, Rémy
Maione, Federica
Brundu, Serena
Cojocaru, Carina Florina
Bouvet, Philippe
Bousquet, Corinne
Gazeau, Florence
Tournigand, Christophe
Courty, José
Giraudo, Enrico
Cohen, José L.
Cascone, Ilaria
author_sort Ponzo, Matteo
collection PubMed
description
format Online
Article
Text
id pubmed-9776549
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97765492022-12-23 Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265 Ponzo, Matteo Debesset, Anais Cossutta, Mélissande Chalabi-Dchar, Mounira Houppe, Claire Pilon, Caroline Nicolas-Boluda, Alba Meunier, Sylvain Raineri, Fabio Thiolat, Allan Nicolle, Rémy Maione, Federica Brundu, Serena Cojocaru, Carina Florina Bouvet, Philippe Bousquet, Corinne Gazeau, Florence Tournigand, Christophe Courty, José Giraudo, Enrico Cohen, José L. Cascone, Ilaria Cancers (Basel) Correction MDPI 2022-12-14 /pmc/articles/PMC9776549/ /pubmed/36551754 http://dx.doi.org/10.3390/cancers14246160 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Ponzo, Matteo
Debesset, Anais
Cossutta, Mélissande
Chalabi-Dchar, Mounira
Houppe, Claire
Pilon, Caroline
Nicolas-Boluda, Alba
Meunier, Sylvain
Raineri, Fabio
Thiolat, Allan
Nicolle, Rémy
Maione, Federica
Brundu, Serena
Cojocaru, Carina Florina
Bouvet, Philippe
Bousquet, Corinne
Gazeau, Florence
Tournigand, Christophe
Courty, José
Giraudo, Enrico
Cohen, José L.
Cascone, Ilaria
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title_full Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title_fullStr Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title_full_unstemmed Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title_short Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
title_sort correction: ponzo et al. nucleolin therapeutic targeting decreases pancreatic cancer immunosuppression. cancers 2022, 14, 4265
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776549/
https://www.ncbi.nlm.nih.gov/pubmed/36551754
http://dx.doi.org/10.3390/cancers14246160
work_keys_str_mv AT ponzomatteo correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT debessetanais correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT cossuttamelissande correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT chalabidcharmounira correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT houppeclaire correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT piloncaroline correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT nicolasboludaalba correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT meuniersylvain correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT rainerifabio correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT thiolatallan correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT nicolleremy correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT maionefederica correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT brunduserena correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT cojocarucarinaflorina correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT bouvetphilippe correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT bousquetcorinne correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT gazeauflorence correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT tournigandchristophe correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT courtyjose correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT giraudoenrico correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT cohenjosel correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265
AT casconeilaria correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressioncancers2022144265